Facebook
Twitter
LinkedIn
Forward
4th Annual Conference on Precision Psychiatry: Innovation to Implementation
Please Note* This program will be held Virtually via Zoom Video Livestream. All program times listed are in Eastern Daylight Time (EDT)
The Annual Conference on Precision Psychiatry, hosted by the MGH Center for Precision Psychiatry, is becoming a leading venue for showcasing advances in the application of precision medicine approaches to psychiatric research and clinical practice. The Conference will be held virtually over the course of two days: Thursday, September 26th and Friday, September 27th, 2024.
Pricing
MDs/Doctoral-Level Professionals: $300
Other Professionals: $200
Students/fellows/interns: Free
BEFORE YOU REGISTER: Important Notice
You must create an account through the MGH Psychiatry Academy to register for this event. MGH Psychiatry Academy accounts are not limited to MGH employees. We welcome attendees from around the world and from any organization.
E-SYLLABUS
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by August 29, 2024. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Target Audience
This program is intended for clinicians, researchers, trainees, students, investors, industry leaders, and all those interested in mental health, healthcare innovation, and research across all geographic locations
Learning Objectives
By the end of this program, participants will be able to:
- Analyze the potential impact of precision psychiatry tools, outcomes, and techniques in research and clinical practice.
- Evaluate the role of precision psychiatry in predicting treatment response and developing targeted interventions for individuals with mental health conditions.
- Identify the key concepts, methodologies, and challenges related to the use of AI and machine learning in precision psychiatry.
- Evaluate the value of digital technologies in improving mental health conditions for patients.
- Discover how genomics and precision therapeutics can be utilized for personalize mental health treatments.
- Identify the ethical, legal, and social implications of precision psychiatry and discuss and evaluate strategies to address these issues.
- Develop strategies to enhance collaboration among researchers, clinicians, patients, and stakeholders to advance the field of precision psychiatry.
- Describe the importance of implementation science in the successful integration of precision psychiatry into clinical practice.
Accreditation
In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
7.0 Physicians
MGH Institute of Health Professions designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.7.0 Nursing Contact Hours
MGH Institute of Health Professions designates this activity for 7.0 contact hours for nurses.
7.0 Social Workers
As a Jointly Accredited Organization, MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 7.0 clock hours for continuing education credits.7.0 IPCE Credit
As a Jointly Accredited Organization, MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 7.0 clock hours for continuing education credits.In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Gold Sponsor
Bristol-Myers Squibb
Silver Sponsors
Otsuka & Circular Genomics
Bronze Sponsor
HMNC Brain Health
4th Annual Conference on Precision Psychiatry
Thursday September 26th - Friday, September 27th, 2024
PROGRAM AGENDA
DAY ONE: Thursday September 26th, 2024 (12:00 PM - 4:15 PM EDT)
Time | Content | Speaker | |
12:00pm-12:10pm | Welcome Remarks | JORDAN W. SMOLLER, MD, ScD Director, MGH Center for Precision Psychiatry; Professor of Psychiatry, Harvard Medical School; Director, Psychiatric and Neurodevelopmental Genetics Unit, MGH Center for Genomic Medicine | |
12:10pm-12:40pm | Conference Keynote | AI for Mental Health in This World Isaac Kohane, MD, PhD Professor & Chair, Dept of Biomedical Informatics, Harvard Medical School, Editor-in-Chief, NEJM AI | |
12:40pm-1:00pm | Moderated Discussion/Q&A: Moderator: JORDAN W. SMOLLER, MD, ScD | ||
1:00pm-1:05pm | Brief Section Introduction | ||
1:05pm-1:50pm | An Industry Perspective on Precision Therapeutics | ||
1:05pm-1:50pm | Panel Moderator: Maurizio Fava, MD | Amit Etkin, MD, PhD Founder and CEO, Alto Neuroscience Adjunct Professor, Stanford University Nikolaos Mellios, MD PhD Chief Scientific Officer, Circular Gennomics Chia-Yen Chen, ScD Associate Director, Computation Biology and Genomics; Genomic Medicine, Translational Sciences, Biogen
| |
1:50pm-2:00pm | BREAK | ||
2:00pm-2:05pm | Brief Section Introduction | ||
2:05pm-3:05pm | Computational Psychiatry: Modeling Brain and Behavior | ||
2:05pm-2:25pm | From Individual Level Precision Psychiatry (ILPP) to Population Level Precision Psychiatry (PLPP) Martin P. Paulus, MD Scientific Director and President, Laureate Institute for Brain Research | ||
2:25pm-2:45pm | Computational Models for Precision Psychiatry Frederike Petzschner, PhD Assistant Professor, Department of Psychiatry and Human Behavior, Carney Institue for Brain Science, Brown University. | ||
2:45pm-3:05pm | Highlighted Discussion/Q&A: Moderator: Justin Baker, MD, PhD Associate Professor of Psychiatry, Harvard Medical School, Director, Laboratory for Functional Neuroimaging and Bioinformatics, McLean Hospital | ||
3:05pm-3:10pm | Brief Section Introduction | ||
3:10pm-4:10pm | In Search of Disorder Subtypes: A Path to Precision? | ||
3:10 pm-3:30pm | Probing and Rescuing Dysfunctional Brain Circuits in Depression Conor Liston, PhD Professor of Neuroscience and Psychiatry, Weill Cornell Medicine | ||
3:30pm-3:50pm | Investigating MDD Heterogeneity Using Polygenic Methods Na Cai, DPhil Principal Investigator, Helmholtz Munich, Pioneer Campus | ||
3:50pm-4:10pm | Highlighted Discussion/Q&A: Moderator: Avram Holmes, PhD Associate Professor, Department of Psychiatry, Rutgers University | ||
4:10pm-4:15pm | Closing Remarks | ||
DAY TWO: Friday, September 27th, 2024 (9:00 AM - 1:05 PM EDT)
Time | Content | Speaker |
9:00am-9:10am | Welcome Remarks | JORDAN W. SMOLLER, MD, ScD Director, MGH Center for Precision Psychiatry; Professor of Psychiatry, Harvard Medical School; Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public Health; Director, Psychiatric and Neurodevelopmental Genetics Unit, MGH Center for Genomic Medicine |
9:10am-9:40am | Conference Keynote | What Can a Smartwatch & Smartphone Characterize, Beyond Survyes, Sleep, and Steps? Rosalind Picard, Sc.D., FIEEE Founder and Director of Affective Computing Research, MIT, Media Lab |
9:40am-10:00am | Moderated Discussion/Q&A: Moderator: Matthew Nock, PhD | |
10:00am-10:05am | Brief Section Introduction | |
10:05am-10:50am | Ethical, Legal, and Social Controversies in Precision Psychiatry | |
10:05am-10:50am | Panel
Moderator: Jordan W. Smoller, MD, ScD
| Paul Appelbaum, MD Dollard Professor of Psychiatry, Medicine & Law, Columbia University Francis Shen, PhD Professor of Law & Faculty Member, Graduate Program in Neuroscience, University of Minnesota; Chief Innovation Officer, Center for Law, Brain & Behavior Anna C F Lewis, DPhil Research Scientist, Genomes2People Research Program, Division of Genetics, Brigham and Women's Hospital, and Harvard Medical School |
10:50am-10:55am | Brief Section Introduction | |
10:55am-11:55am | Can We Improve Prediction and Early Prevention? | |
10:55am-11:15am | WARN-D: Building an Early Warning System for Depression Eiko Fried, PhD Associate Professor in Clinical Psychology, Leiden University | |
11:15am-11:35am | Scalable Digital Tools for Improved Access to Mental Health Care: Accurate Risk Stratification and Early Preventive Intervention Katharina Schultebraucks, PhD Associate Professor, Psychiatry and Population Health, Co-Director, Computational Psychiatry, Department of Psychiatry, NYU Grossman School of Medicine | |
11:35am-11:55am | Highlighted Discussion/Q&A: Moderator: Karmel Choi, PhD. Director, Precision Prevention Program, MGH Center for Precision Psychiatry | |
11:55am-12:00pm | Brief Section Introduction | |
12:00pm-1:00pm | Precision Treatment Selection: Who Needs What and When? | |
12:00pm-12:20pm | Recent Advances in the Application of Data-Driven Prediction Models in Behavioral Health Delivery Systems Rob J. DeRubeis, PhD Professor of Psychology, University of Pennsylvania | |
12:20pm-12:40pm | Precision Psychiatry and Depressive Disorders: Aspiration, Fit of Purpose and Future Vistas Roger McIntyre, MD, FRCPC Professor of Psychiatry and Pharmacology, University of Toronto | |
12:40pm-1:00pm | Highlighted Discussion/Q&A: Moderator: Roy Perlis, MD | |
1:00pm-1:05pm | Closing Remarks | |
JORDAN W. SMOLLER, MD, ScD
Director, MGH Center for Precision Psychiatry; Professor of Psychiatry, Harvard Medical School; Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public Health; Director, Psychiatric and Neurodevelopmental Genetics Unit, MGH Center for Genomic Medicine
MAURIZIO FAVA, MD
Psychiatrist-in-Chief, MGH; Vice Chair, MGH Executive Committee of Research; Executive Director, MGH Clinical Trials Network
Isaac Kohane, MD, PhD
Professor & Chair, Dept of Biomedical Informatics, Harvard Medical School, Editor-in-Chief, NEJM AI
Paul Appelbaum, MD
Dollard Professor of Psychiatry, Medicine & Law, Columbia University
Na Cai, DPhil
Principal Investigator, Helmholtz Munich, Pioneer Campus
Rob J. DeRubeis, PhD
Professor of Psychology, University of Pennsylvania
Eiko Fried, PhD
Associate Professor in Clinical Psychology, Leiden University
Anna C F Lewis, DPhil
Research Scientist, Genomes2People Research Program, Division of Genetics, Brigham and Women's Hospital, and Harvard Medical School
Conor Liston, PhD
Professor of Neuroscience and Psychiatry, Weill Cornell Medicine
Roger McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology, University of Toronto
Martin P. Paulus, MD
Scientific Director and President, Laureate Institute for Brain Research
Rosalind Picard, Sc.D., FIEEE
Founder and Director of Affective Computing Research
Massachusetts Institute of Technology, Media Lab
Katharina Schultebraucks, PhD
Associate Professor, Psychiatry and Population Health
Co-Director, Computational Psychiatry, Department of Psychiatry, NYU Grossman School of Medicine
Francis Shen, PhD
Professor of Law & Faculty Member, Graduate Program in Neuroscience, University of Minnesota; Chief Innovation Officer, Center for Law, Brain & Behavior
Disclosures:
Dr. Smoller receives research funding from Biogen and is on the Scientific Advisory Board of Sensorium Therapeutics, Inc.
Dr. Fava receives research support from Abbvie; Acadia Pharmaceuticals; Aditum Bio Management Company, LLC;
Allergan, Alkermes, Inc.; Altimate Health Corporation; Alto Neuroscience,
Inc.; Ancora Bio, Inc.; Angelini S.p.A; Aptinyx; Arbor Pharmaceuticals LLC;
Axsome; Benckiser Pharmaceuticals, Inc.; BioClinica, Inc.; Biogen;
BioHaven; BioShin Limited; Cambridge Science Corporation; Centrexion
Therapeutics Corporation; Cybin IRL Limited; Damona Pharmaceuticals;
EmbarkNeuro; Eliem Therapeutics LTD; Gate Neurosciences, Inc.;
GenOmind, LLC; Gentelon, LLC; Gerbera Therapeutics, Inc.; GH Research
Ireland Limited; Happify; Johnson & Johnson; Lundbeck Inc.; Marinus
Pharmaceuticals; Medpace, Inc.; Millennium Pharmaceutics, Inc.; Minerva
Neurosciences; NeuraWell Therapeutics, Inc.; Neurocrine Biosciences,
Inc.; Novaremed; Otsuka; Peachtree BioResearch Solutions Inc.; Pfizer;
Premiere Research International; Praxis Precision Medicines; Protagenic
Therapeutics, Inc.; Relmada Therapeutics Inc.; Shenox Pharmaceuticals;
Stanley Medical Research Institute (SMRI); Takeda; University of Michigan;
University of Florida Board of Trustees; Vistagen; WinSanTor, Inc.; Xenon
Pharmaceuticals, Inc.; XW Pharma Ltd.; National Institute of Drug Abuse
(NIDA); National Institutes of Health (NIH); National Institute of Mental
Health (NIMH); and PCORI.
He also has equity holdings in Compellis (no longer in existence); Neuromity; Psy Therapeutics; Revival Therapeutics (no longer in existence); Sensorium Therapeutics and receives royalties and has patents for Sequential Parallel Comparison Design (SPCD), licensed by
MGH to Pharmaceutical Product Development, LLC (PPD) (US_7840419,
US_7647235, US_7983936, US_8145504, US_8145505); patent
application for a combination of Ketamine plus Scopolamine in Major
Depressive Disorder (MDD), licensed by MGH to Biohaven; and patents for
pharmacogenomics of Depression Treatment with Folate (US_9546401,
US_9540691) licensed to Nestle and for Compound for improving l-arginine
bioavailability (US_11,655,210) licensed to DimeRx. Copyright for the MGH
Cognitive & Physical Functioning Questionnaire (CPFQ), Sexual
Functioning Inventory (SFI), Antidepressant Treatment Response
Questionnaire (ATRQ), Discontinuation-Emergent Signs & Symptoms
(DESS), Symptoms of Depression Questionnaire (SDQ), Anxiety
Symptoms Questionnaire (ASQ), and SAFER; Belvoir; Lippincott, Williams
& Wilkins; Wolkers Kluwer; World Scientific Publishing Co. Pte.Ltd.
Nature of Financial Relationship Royalty/patent
Accreditation
In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
7.0 Physicians
MGH Institute of Health Professions designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
7.0 Nursing Contact Hours
MGH Institute of Health Professions designates this activity for 7.0 contact hours for nurses.
7.0 Social Workers
As a Jointly Accredited Organization, MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 7.0 clock hours for continuing education credits.
7.0 IPCE Credit
As a Jointly Accredited Organization, MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 7.0 clock hours for continuing education credits.
Available Credit
- 7.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 7.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 7.00 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 7.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 7.00 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 7.00 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 7.00 Continuing Education (CE) credits per presentation for psychologists.
Price
Course Directors/Planners
Jordan Smoller, MD, ScD – Director, MGH Center for Precision Psychiatry; Director, MGH Psychiatric and Neurodevelopmental Genetics Unit; Professor of Psychiatry, Harvard Medical School; Professor in Epidemiology, T.H. Chan Harvard School of Public Health
Victoria Dobrzycki, BS – Marketing and Administrative Coordinator, MGH Center for Precision Psychiatry
Karmel Choi, PhD – Director, Precision Prevention Program at MGH Center for Precision Psychiatry; Clinical Psychologist at MGH; Assistant Professor at Harvard Medical School
Ashley Seiger, MSc – Program Director, MGH Center for Precision Psychiatry
Hardware/Software Specifications
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Minimum Requirements
Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit